| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 12, 2024 | Buy | $15.05 | 26,963 | 405,793 | 692,511 | Sep 16, 2024, 05:12 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 16, 2024 | Buy | $17.13 | 13,037 | 223,324 | 705,548 | Sep 16, 2024, 05:12 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 09, 2024 | Buy | $15.21 | 9,500 | 144,495 | 657,048 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 10, 2024 | Buy | $15.19 | 8,500 | 129,115 | 665,548 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 06, 2024 | Buy | $15.29 | 26,000 | 397,540 | 647,548 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 29, 2024 | Buy | $14.03 | 10,000 | 140,300 | 135,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 30, 2024 | Buy | $14.02 | 10,000 | 140,200 | 145,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Sep 03, 2024 | Buy | $15.81 | 20,000 | 316,263 | 165,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 20, 2024 | Buy | $12.97 | 27,055 | 350,903 | 41,920 | Aug 22, 2024, 04:29 PM | |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | Aug 21, 2024 | Buy | $12.93 | 12,945 | 167,379 | 54,865 | Aug 22, 2024, 04:29 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | May 30, 2024 | Option Exercise | $30.00 | 2,486,192 | 74,585,760 | 0 | May 30, 2024, 06:22 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | May 30, 2024 | Option Exercise | $30.00 | 500,000 | 15,000,000 | 0 | May 30, 2024, 06:22 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | May 30, 2024 | Option Exercise | $30.00 | 59,462 | 1,783,860 | 0 | May 30, 2024, 06:22 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Feb 28, 2023 | Sale | $25.02 | 60 | 1,501 | 2,486,192 | Mar 01, 2023, 04:41 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Jan 24, 2023 | Sale | $25.72 | 4,335 | 111,478 | 2,486,315 | Jan 24, 2023, 06:46 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Jan 23, 2023 | Sale | $25.36 | 21,665 | 549,364 | 2,490,587 | Jan 24, 2023, 06:46 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Dec 19, 2022 | Sale | $25.56 | 26,000 | 664,443 | 2,513,006 | Dec 20, 2022, 04:59 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Nov 17, 2022 | Sale | $27.88 | 26,000 | 724,910 | 2,557,293 | Nov 18, 2022, 05:06 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Oct 17, 2022 | Sale | $29.59 | 26,000 | 769,443 | 2,581,271 | Oct 18, 2022, 04:37 PM | |
| AOLS | AEOLUS PHARMACEUTICALS, INC. | Lappe Mark | 10% Owner | Mar 16, 2011 | Sale | $0.61 | 3,799,380 | 2,317,622 | 4,349,432 | Mar 17, 2011, 05:54 PM | |
| AOLS | AEOLUS PHARMACEUTICALS, INC. | Lappe Mark | 10% Owner | Mar 15, 2011 | Sale | $0.76 | 193,234 | 146,858 | 8,148,812 | Mar 17, 2011, 05:54 PM | |
| AOLS | AEOLUS PHARMACEUTICALS, INC. | Lappe Mark | 10% Owner | Feb 15, 2011 | Sale | $0.95 | 7,000 | 6,650 | 8,399,646 | Feb 17, 2011, 07:53 PM | |
| AOLS | AEOLUS PHARMACEUTICALS, INC. | Lappe Mark | 10% Owner | Feb 16, 2011 | Sale | $0.97 | 57,600 | 55,872 | 8,342,046 | Feb 17, 2011, 07:53 PM |
Menu